載入...

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD mortality is on the rise. The etiology of MAFLD is...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pharmaceuticals (Basel)
Main Authors: Abou Assi, Reem, Abdulbaqi, Ibrahim M., Siok Yee, Chan
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001129/
https://ncbi.nlm.nih.gov/pubmed/33806527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030215
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!